ABSTRACT: Adverse tissue reactions to metal implants, including pseudotumors, can compromise implant functionality and survivorship. The identification of specific proteins in the synovial fluid (SF) of hip arthroplasty patients with a pseudotumor may lead to a better understanding of the underlying pathomechanisms. The objective of the present study was to compare the protein content of SF from patients with a short-term metal-on-metal hip implant associated with a pseudotumor and patients with a long-term metal-onpolyethylene hip implant associated with periprosthetic osteolysis. Discovery proteomics was used to identify differentially abundant proteins in albumin-depleted SF. In toto, 452 distinct proteins (present in at least half of the patients in one or both groups) were identified. Thirty of these 452 proteins were differentially abundant between the two groups, including two potential biomarkers: 6-phosphogluconate dehydrogenase (which plays a major protective role against oxidative stress) for the pseudotumor group, and scavenger receptor cysteine-rich type 1 protein M130 (which is involved in low-grade inflammation) for the periprosthetic osteolysis group. Other differentially abundant proteins identified suggest the presence of an adaptive immune response (particularly a type-IV hypersensitivity reaction), necrosis, and greater oxidative stress in patients with a pseudotumor. They also suggest the presence of an innate immune response, oxidative stress, tissue remodeling, and apoptosis in both patient groups, although differences in the specific proteins identified in each group point to differences in the pathomechanisms. Overall, results provide insights into the molecular mechanisms underlying metal-related pseudotumors and periprosthetic osteolysis, and may ultimately help elucidate pseudotumor etiology and assess the risk that asymptomatic pseudotumors will develop into an aggressive lesion. ß
Adverse tissue reactions to metal implant wear and/or corrosion remain a major complication because they can compromise implant functionality and survivorship. [1] [2] [3] [4] These adverse reactions include pseudotumors, defined as destructive solid or cystic periprosthetic soft tissue masses, often associated with pain. Although relatively uncommon, pseudotumors have been associated with metal wear and corrosion at modular interfaces in patients with either a metal-onmetal (MoM) or a metal-on-polyethylene (MoPE) hip implant, 2, 4 and they frequently lead to revision surgery with poor outcome due to bone and soft tissue destruction. 5 In addition, pseudotumors have been reported in up to 61% of asymptomatic patients, 6, 7 and there is currently no consensus on how to monitor these patients 8 for whom the risk of developing a symptomatic pseudotumor remains unknown. 9, 10 Consequently, understanding the pathomechanisms underlying pseudotumors could provide critical insights into their etiology and the risk that they will develop into an aggressive lesion, as well as provide guidance in the assessment of patients with a painful metal implant and/or an asymptomatic effusion.
Pseudotumors present histological features that are consistent with an inflammatory immune response (e.g., macrophages with phagocytosed metal particles) as well as an adaptive immune response (e.g., lymphocyte aggregates). 10, 11 Previous histological studies have also shown the presence of extensive necrosis 11, 12 as well as vascular changes. 10 In contrast, periprosthetic osteolysis is dominated by a macrophage response to wear particles and is therefore attributed predominantly to an innate immune response. 13, 14 Because hip synovial fluid (SF), an ultrafiltrate of plasma containing proteins produced by proximal joint tissues, 15, 16 is in direct contact with the soft tissues surrounding hip implants, its protein composition may provide insights into the pathomechanisms leading to soft-tissue adverse reactions. SF is considered an excellent source for the identification of proteins associated with pathological joint conditions, 17 and recent proteomic studies of SF have successfully identified proteins and pathways associated with rheumatoid arthritis, osteoarthritis, and juvenile arthritis. 17, 18 Proteomics has also been used to identify cobalt-and chromium-binding proteins in periprosthetic tissues of patients with a failed MoM hip implant associated with an adverse local tissue reaction. 19 The identification of differentially abundant proteins in the SF of patients with a failed hip implant associated with a pseudotumor may therefore lead to a better understanding of the pathomechanisms underlying pseudotumors at the molecular level. Based on previous immunohistochemical studies of pseudotumors, these differentially abundant proteins are expected to reflect the presence of an adaptive immune response, 10, 11 soft tissue necrosis, 11, 12 and vascular changes. 10 In addition, because metal products (especially metal ions) have been shown to induce oxidative stress, 19, 20 and because a link has been suggested between elevated oxidative stress and the formation of pseudotumors, 19 proteins in the SF of patients with a pseudotumor are also expected to reflect the presence of oxidative stress. In contrast, proteins in the SF of patients with periprosthetic osteolysis are expected to predominantly reflect the presence of an innate immune response and bone tissue remodeling. 13, 14, 21 The objective of the present study was to compare the protein content of SF from patients with a short-term MoM hip implant associated with a pseudotumor and patients with a long-term MoPE hip implant associated with periprosthetic osteolysis, using discovery proteomics. Overall, results provide insights into the molecular mechanisms underlying these pathologies, particularly metalrelated pseudotumors.
MATERIALS AND METHODS
Unless otherwise specified, water was reagent grade (ASTM Type I), and all chemicals were analytical grade.
Patient Groups
This level III retrospective cohort study has been approved by the Ottawa Health Science Network Research Ethics Board, and written informed consent was obtained from all participants. Exclusion criteria included previous revision arthroplasty of the hip with the failed implant, fracture, diagnosed conditions that can affect the immune system (active infection, rheumatoid arthritis, HIV infection, and lupus), and SF contamination by blood plasma and hemolysate exceeding 3.0% and 1.0% (v/v), respectively. Consenting patients who underwent revision surgery of a failed MoM or MoPE hip implant at The Ottawa Hospital were recruited, unless they met any of the exclusion criteria. Patients were divided into two groups: those with a short-term (<7 years) MoM hip implant associated with a pseudotumor (n ¼ 6: 2 hip resurfacings and 4 total hip replacements), and those with a long-term (!10 years) MoPE hip implant associated with periprosthetic osteolysis (n ¼ 6). Patient demographics and implant information are provided in Table 1 . Pseudotumors were diagnosed or confirmed intraoperatively with the observation of a destructive solid or cystic mass in close proximity to the implant. Osteolysis, defined as an expansile lesion associated with bone loss, was diagnosed by radiographic imaging.
Synovial Fluid Collection
Patients were fasted preoperatively from liquids and solids for 2 and 12 h, respectively. SF samples were collected intraoperatively by the surgeon using ultrasound-guided hip arthrocentesis performed under direct visualization, after incision but prior to capsulotomy. SF was aspirated using a sterile 20-ml disposable polypropylene syringe and 18G needle (Becton, Dickinson and Co., Franklin Lakes, NJ), transferred into a sterile polypropylene specimen container (Starplex Scientific, Etobicoke, ON), and supplemented with a protease inhibitor cocktail (catalog no. P8340; SigmaAldrich, St-Louis, MO) to a final concentration of 10% (v/v). An aliquot of supplemented SF (!100 ml in a 2-ml polypropylene cryovial; Greiner Bio-One, Monroe, NC) was frozen and stored in liquid N 2 for future quantification of contamination by blood plasma. The remaining SF was centrifuged (10 min at 1,000g at 4˚C) to remove cells and insoluble material, and the resulting supernatant was centrifuged (10 min at 16,000g at 4˚C) to remove finer insoluble material. Aliquots of this supernatant (!200 ml in 2-ml polypropylene cryovials; Greiner Bio-One) were frozen and stored in liquid N 2 for future proteomic analysis and quantification of contamination by hemolysate.
Quantification of Synovial Fluid Contamination by Blood
Contamination of SF and SF supernatants (described above) by blood plasma and hemolysate, respectively, was determined by measuring hemoglobin in freshly thawed SF and SF supernatants using the colorimetric hemiglobin (i.e., methemoglobin) cyanide (HiCN) method. 22 Briefly, aliquots (40 ml) of well-resuspended samples were mixed with 1 ml of Drabkin , and incubated at room temperature for 10 min. Absorbance measurements were performed at 540 nm in 96-well flat-bottom clear polystyrene microplates (Greiner Bio-One) using a hybrid microplate reader (BioTek Instruments, Winooski, VT). Hemoglobin concentration in the SF and SF supernatants was determined using a hemoglobin standard curve prepared with freshly collected blood containing a known hemoglobin concentration pre-determined by a complete blood count (CBC) performed by the Eastern Ontario Regional Laboratory Association (EORLA; Ottawa, ON). The contamination of each SF supernatant (used for the proteomic analysis) by blood plasma and hemolysate was then calculated (see Supplementary Material, Appendix I) using the hemoglobin concentration measured in the SF and SF supernatant, as well as the corresponding patient whole blood hemoglobin concentration and hematocrit determined by a CBC. The patient CBC were performed by EORLA on fresh peripheral blood collected preoperatively, (by venipuncture of the median cubital vein) into 6-ml trace-elements sodium heparin evacuated tubes (Greiner Bio-One). Contamination was expressed as the percentage of the volume of SF supernatant occupied by blood plasma or hemolysate (data not shown).
Immunodepletion of Albumin From Synovial Fluid SF was depleted of albumin to enhance the detection of lower abundance proteins. 23 Briefly, thawed aliquots of SF supernatants were centrifuged (30 min at 21,000g at 4˚C), and the 'solvent' portion of the supernatant was exchanged with Buffer A (catalog no. 5185-5987; Agilent Technologies, Santa Clara, CA) supplemented with a protease inhibitor cocktail (cOmplete TM , Mini, EDTA-free; Roche Diagnostics, Indianapolis, IN) by centrifugal filtration (4,700g at 4˚C), using 4-ml capacity 5-kDa molecular weight cut-off polyethersulfone filters (Agilent Technologies). The retentates were filtered through a 22-mm pore-size membrane (Agilent Technologies) by centrifugation (16,000g at 4˚C) and depleted of albumin using a 0.45-ml affinity removal spin cartridge (catalog no. 5188-8825; Agilent Technologies), as per the manufacturer's instructions. Aliquots of albumin-depleted samples were frozen and stored at À80˚C for later analysis by mass spectrometry (MS). Protein concentration was determined using the Bradford colorimetric assay and bovine serum albumin as the protein standard (Thermo Scientific, Rockford, IL). Depletion of albumin was confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis performed using precast midi-format gradient gels (Any kD TM Criterion TM Precast Gels; Bio-Rad, Hercules, CA). The gels were stained with Kang's colloidal Coomassie Brilliant Blue G-250 24 (data not shown).
Synovial Fluid Preparation and Fractionation
The filter-aided sample preparation (FASP) procedure used was adapted from Wi sniewski et al. 25 (Supplementary Material, Appendix II).
Mass Spectrometry and Data Analysis
MS analysis, using a capillary high-performance liquid chromatography (HPLC) system (Agilent 1100 Series; Agilent Technologies) coupled with a hybrid Fourier transform mass spectrometer (LTQ Orbitrap XL TM ; Thermo Scientific) equipped with a nano-electrospray ionization (ESI) interface, was performed as previously described by Ning et al., 26 with minor modifications (Supplementary Material, Appendix II).
The output from MaxQuant software 27 (version 1.2.2.5) was analyzed using Perseus software 28 (version 1.4.1.3). Proteins identified only by a modification site, proteins derived from the reversed part of the decoy database, and commonly occurring contaminant proteins were excluded from the analysis. Only proteins present in at least half of the patients in one or both groups were included in the statistical analysis. This analysis was performed using a two-sided t-test (on log 10 -transformed data), and the Significance B test 27 with Benjamini-Hochberg multiple testing correction to control the false discovery rate (FDR) at 5%. A p-value <0.05 was considered significant. Protein abundance data are presented as an MA plot. The biological process analysis (i.e., the identification of the biological processes in which specific proteins are involved) was performed using the Gene Ontology (GO) database 29 and Information Hyperlinked Over Proteins (iHOP 30 ; http://www.ihop-net.org/), as well as literature searches.
RESULTS

Differentially Abundant Synovial Fluid Proteins
In toto, 452 distinct proteins (present in at least half of the patients in one or both groups) were identified by proteomic analysis of albumin-depleted SF (the complete list of proteins is provided as Supplementary Material, Table S1 ). Of these 452 proteins, 30 were differentially abundant between the two groups PROTEOMICS OF HIP SYNOVIAL FLUID ( Fig. 1 and Table 2 ). Seventeen of these 30 proteins were more abundant in the SF of patients with a pseudotumor, while 13 were more abundant in the SF of patients with periprosthetic osteolysis. Two of the differentially abundant proteins had an absolute specificity and sensitivity for one group: 6-phosphogluconate dehydrogenase for the pseudotumor group, and scavenger receptor cysteine-rich type 1 protein M130 for the periprosthetic osteolysis group. Of the 30 differentially abundant proteins, 21 (i.e., 70%) were annotated in the GO Database as secreted proteins, 6 (i.e., 20%) as cytosolic or nuclear proteins that are not secreted, and 3 (i.e., 10%) as membrane proteins that are not secreted (Table 2) . Interestingly, all 5 of the exclusively intracellular proteins (i.e., cytosolic or nuclear proteins that are not secreted) and 2 of the 3 membrane proteins that are not secreted were more abundant in the pseudotumor group.
Biological Process Analysis
Twenty-seven of the 30 differentially abundant proteins (i.e., 90%) had a specificity ! 0.67 and a sensitivity ! 0.50. These proteins, many of which are multifunctional, were organized into overlapping groups based on the biological processes in which they are involved: innate or adaptive immune response, oxidative stress, carbohydrate metabolism, tissue remodeling, and cell death. Only one protein (erythrocyte band 7 integral membrane protein) had to be excluded from the biological process analysis because it remains poorly characterized.
Immune Response
Most of the proteins differentially abundant between the two patient groups (21 out of 30, i.e., 70%) are involved in the immune response (Table 3) . These proteins were subgrouped into proteins involved in the innate and adaptive immune responses. It should be Figure 1 . Distribution of Protein Abundance. Data are presented as an MA plot where M represents the differential protein abundance between the two patient groups (log 2 of average LFQ intensity in the pseudotumor group À log 2 of average LFQ intensity in the periprosthetic osteolysis group), and A represents the average protein abundance ((log 2 of average LFQ intensity in the pseudotumor group þ log 2 of average LFQ intensity in the periprosthetic osteolysis group)/2). Proteins significantly more abundant in the pseudotumor group (n ¼ 17) and in the periprosthetic osteolysis group (n ¼ 13) are labeled green and red, respectively, and individually identified. Proteins non-significantly differentially abundant between the two patient groups are labeled gray.
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noted that there is considerable overlap between these two subgroups since many of the proteins involved in the innate immune response are also known to play a role in the adaptive immune response.
The number of differentially abundant proteins involved in the innate immune response was similar in both patient groups. These proteins included extracellular histones and azurocidin (more abundant in the pseudotumor group), as well as chitotriosidase-1 and scavenger receptor cysteine-rich type 1 protein M130 (more abundant in the periprosthetic osteolysis group).
Differentially abundant proteins involved in the adaptive immune response were also identified in both patient groups. However, a greater number of these proteins was present in the pseudotumor group, including lactotransferrin, metalloproteinase inhibitor 1, and stromelysin-1.
Oxidative Stress, Carbohydrate Metabolism, and Tissue Remodeling The number of differentially abundant proteins involved in oxidative stress was the same in both patient groups (Table 4) . However, one of the proteins, 6- Sensitivity: percentage of patients in group 1 in which the abundance of the indicated synovial fluid protein is higher than the median abundance of all patients in groups 1 and 2.
PROTEOMICS OF HIP SYNOVIAL FLUID phosphogluconate dehydrogenase, had an absolute specificity and sensitivity for the pseudotumor group. This protein, along with glycogen phosphorylase, which had a high specificity and sensitivity for the pseudotumor group, were the only two differentially abundant proteins involved in carbohydrate metabolism.
Finally, the number of differentially abundant proteins involved in tissue remodeling was similar in both patient groups (Table 4) . These proteins included annexin-A3 (more abundant in the pseudotumor group), vasorin and osteopontin (more abundant in the periprosthetic osteolysis group).
Cell Death
The differentially abundant proteins involved in apoptosis and necrosis were subgrouped into proteins that positively and negatively regulate these processes (Table 5A and B, respectively). Overall, proteins involved in apoptosis were more abundant in the pseudotumor group, and included complement C1q subcomponent subunit A (positive regulation of apoptosis) and annexin A3 (negative regulation of apoptosis). Proteins more abundant in the periprosthetic osteolysis group included osteopontin and CD44. 
DISCUSSION
The present study used discovery proteomics to compare the protein content of SF from patients with a short-term MoM hip implant associated with a pseudotumor and patients with a long-term MoPE hip implant associated with periprosthetic osteolysis. In toto, 452 distinct proteins were identified (present in at least half of the patients in one or both groups), and 30 of these were differentially abundant between the two patient groups, reflecting specific differences between these two groups. Two of these 30 proteins had an absolute specificity and sensitivity for one of the groups: 6-phosphogluconate dehydrogenase (which plays a major protective role against oxidative stress) for the pseudotumor group, and scavenger receptor cysteine-rich type 1 protein M130 (which is involved in low-grade inflammation) for the periprosthetic osteolysis group. Overall, results provide insights into the molecular mechanisms underlying these pathologies, particularly metal-related pseudotumors.
Immune Response
Most of the differentially abundant SF proteins identified play a role in immunity. Although the number of differentially abundant proteins involved in the innate response was similar in both groups of patients, differences in the specific proteins involved suggest interesting differences in the pathomechanisms. For example, extracellular histones (family H2A and H2B), which are members of the damage-associated molecular pattern molecules (DAMP), 31 were more abundant in the pseudotumor group where they may contribute to inflammation by activating Toll-like receptors and inflammasome pathways. 31 In addition, the high specificity and sensitivity of azurocidin for the pseudotumor group suggests neutrophil degranulation 32 in the periprosthetic environment. In contrast, phagocytespecific chitotriosidase-1, a chitinase mainly secreted by activated macrophages, may have contibuted to inflammation in the periprosthetic osteolysis group where it was more abundant. Indeed, this protein has been implicated in the pathogenesis of many diseases through the induction of inflammation and faulty tissue remodeling. 33 Scavenger receptor cysteine-rich Note: Although the majority of the proteins listed in this table are also involved in the other biological processes, including the innate and/or adaptive immune response, they play specific roles in the regulation of apoptosis and necrosis. a Exceptions to the general pattern of negative apoptosis regulation have been reported for some of these proteins.
PROTEOMICS OF HIP SYNOVIAL FLUID type 1 protein M130 (also known as CD163), a monocyte/macrophage-specific protein that is expressed at a high level by macrophages in chronically inflamed tissues, 34 was also more abundant in the periprosthetic osteolysis group. The soluble form of this protein was shown to be shed into plasma in response to pro-inflammatory stimuli, 35 and has been proposed as a novel biomarker of low-grade inflammation. 36 Its greater abundance in the SF of patients with periprosthetic osteolysis is therefore consistent with the presence of chronic low-grade periprosthetic inflammation.
A greater number of differentially abundant proteins involved in the adaptive immune response was present in the pseudotumor group. These proteins included lactotransferrin, metalloproteinase inhibitor 1, and stromelysin-1 (also known as matrix metalloproteinase 3), which are known to be involved in type-IV hypersensitivity reactions. [37] [38] [39] Indeed, lactotransferrin, a cell-secreted multifunctional iron-transport protein (also known to bind Cr 3þ 19 ) has been shown to promote delayed-type hypersensitivity. 37, 39 Furthermore, metalloproteinase activity has been used to monitor contact hypersensitivity by in vivo imaging, 38 and the injection of stromelysin-1 in stromelysin-1-deficient mice has demonstrated that this protein is essential for the initiation of contact hypersensitivity. 40 The greater abundance of these proteins in the SF of the pseudotumor group therefore suggests the presence of a type-IV hypersensitivity reaction, which has been suspected in pseudotumor cases. 11 Overall, results are consistent with the presence of an inflammatory response in both patient groups, as well as an adaptive immune response (more specifically a type-IV hypersensitvity reaction) in the pseudotumor group. This finding is in general agreement with the histological observation of a macrophagic response in the periprosthetic osteolysis group, and a lymphocytic or mixed (lymphocytic and macrophagic) response in the pseudotumor group (unpublished data).
Oxidative Stress and Carbohydrate Metabolism
In both patient groups, results are consistent with the presence of oxidative stress, a characteristic response to metal products (particularly metal ions) released from metal wear and corrosion. 19, 20 Nevertheless, the absolute specificity and sensitivity for the pseudotumor group of 6-phosphogluconate dehydrogenase, an enzyme that plays a major protective role against oxidative stress, 41 suggest the presence of greater oxidative stress, which, as proposed by Scharf et al., 19 might explain necrosis and the formation of pseudotumors. 6-Phosphogluconate dehydrogenase, a rate-limiting enzyme of the pentose phosphate pathway, catalyzes the reduction of NADP to NADPH and is therefore critical in counterbalancing oxidative stress via the glutathione system. 41 Toxic levels of iron, which increase oxidative stress, were recently shown to upregulate the expression of this enzyme. 41 6-Phosphogluconate dehydrogenase may therefore play an essential role in protecting cells against reactive oxygen species (ROS) associated with transition metals such as cobalt, which are released from metal implants through wear and corrosion. Interestingly, the results of the present study also showed that glycogen phosphorylase, an enzyme that catalyzes the rate-limiting step of glycogenolysis, had a high specificity and sensitivity for the pseudotumor group. Since glycogenolysis provides the pentose phosphate pathway with the glucose 6-phosphate needed to produce NADPH, glycogenolysis and the pentose phosphate pathway may therefore play a significant role in counterbalancing oxidative stress in patients with a pseudotumor.
Finally, the enzyme g-interferon-inducible lysosomal thiol reductase, which contributes to the maintenance of the cellular redox status via the glutathione system, 31 was more abundant in the periprosthetic osteolysis group. This observation is consistent with the discovery of a connection between oxidative stress and periprosthetic osteolysis in patients with MoPE implants. 42 Overall, results are consistent with the presence of oxidative stress in both patient groups, although differences in the specific proteins identified suggest greater stress in the pseudotumor group.
Tissue Remodeling
Differentially abundant proteins involved in tissue remodeling were identified in both patient groups. However, differences in the specific proteins involved suggest, once again, interesting differences in the pathomechanisms. For example, annexin A3, a protein involved in angiogenesis, 43 was more abundant in the pseudotumor group, suggesting potential vascular remodeling around and/or within pseudotumors. Interestingly, vasorin, a protein shown to modulate vascular response to injury 44 was less abundant in the pseudotumor group. Because the expression of vasorin is downregulated during blood vessel repair, 44 its lower abundance in the pseudotumor group may reflect increased vascular injury in the presence of a pseudotumor.
In contrast, osteopontin, an extracellular matrix protein and proinflammatory cytokine essential to bone remodeling, 45 was more abundant in the periprosthetic osteolysis group. This protein has been shown to play critical roles in Ti particle-induced osteolysis via the orchestration of pro-and antiinflammatory cytokines secreted by macrophages. 46 Its greater abundance in the periprosthetic osteolysis group may therefore have contributed to the osteolysis observed in this group of patients.
Overall, the specific proteins involved in tissue remodeling identified in each patient group suggest more vascular changes in the pseudotumor group and more bone remodeling in the periprosthetic osteolysis group, which is consistent with histological studies of adverse soft-tissue reactions to metal implants 10 and the presence of osteolysis, 13 respectively.
Cell Death
Differentially abundant proteins involved in the regulation (positive or negative) of apoptosis were identified in both patient groups, but the number of distinct proteins was higher in the pseudotumor group. More specifically, complement C1q, a complement component involved in the removal of apoptotic cells, 47 was more abundant in the pseudotumor group. Interestingly, annexin A3, also more abundant in the pseudotumor group but involved in the downregulation of apoptosis, has been associated with cell resistance to Pt 2þ -induced apoptosis, and the intracellular concentration of Pt 2þ of cells exposed to cisplatin has been reported to be lower when annexin A3 is overexpressed. 48 Because Co 2þ has been shown to induce apoptosis in macrophages in vitro 49 and annexin A3 can bind Co 2þ , 50 this protein has the potential to increase resistance to Co 2þ -induced apoptosis in patients with a pseudotumor. In the periprosthetic osteolysis group, most of the differentially abundant proteins involved in apoptosis downregulate this form of programmed cell death. These proteins included osteopontin, which can give pro-survival signals through its interaction with CD44, 51 and could therefore help reduce osteolysis by downregulating apoptosis. 52 Notably, differentially abundant proteins involved in necrosis were identified exclusively in the pseudotumor group (positive regulation only). These proteins, complement C1q subcomponent subunit A and complement C4-B, are part of the classical pathway of complement activation leading to the formation of the complement membrane attack complex (MAC), which induces a necrotic-type cell death. 53 Interestingly, the differential expression of these proteins in the pseudotumor group may also reflect the presence of antibodyantigen complexes and is consistent with the reported presence of B cells in pseudotumors. 10 Finally, all 5 of the differentially abundant proteins that are exclusively intracellular and 2 of the 3 membrane proteins that are not secreted (and therefore likely released in the SF by necrosis) were more abundant in the SF from patients in the pseudotumor group.
Overall, results suggest more extensive necrosis (leading to the release of intracellular and membrane proteins) in patients with a pseudotumor, which is consistent with the histological analysis of the periprosthetic tissues (unpublished data) and published histological studies.
11,12
Limitations of the Study Overall, the present study shows significant differences in the protein content of SF from the two groups of patients analyzed, and provides insights into some of the pathomechanisms underlying metal-related pseudotumors. Although a comparison of the pseudotumor group with patients having a well-functioning implant without a pseudotumor or individuals without an implant would be informative, SF cannot be collected from these patients and individuals for ethical reasons. Notwithstanding, the comparative analysis performed in this study provides much needed insights into the molecular pathomechanisms of pseudotumors in comparison to periprosthetic osteolysis, a more common and overall better understood pathology. Although pseudotumors have been associated with metal wear and corrosion at modular interfaces in patients with either a MoM or a MoPE hip implant, 2,4 only patients with a MoM implant were selected for the pseudotumor group in order to optimize group homogeneity. On the other hand, only patients with a MoPE implant were selected for the osteolysis group since periprosthetic osteolysis is, as just mentioned, a more common and overall better understood pathology typically observed around long-term conventional MoPE hip implants. Finally, the study focused exclusively on pseudotumors around short-term implants to characterize the early phase of this adverse reaction. The study of SF from longer-term pseudotumors might yield different results due to the evolution of the immune response.
Because of the difficulties associated with the collection of SF from the hip joint, the exclusion criteria of the study, the decreasing number of MoM hip arthroplasties being performed, and the relatively low prevalence of pseudotumors, the size of the patient groups used in the present study is relatively small (6 patients per group), but considered adequate for the comparison that was performed. 54 Notwithstanding, it is possible that increasing the number of patients would lead to the identification of additional differentially abundant proteins. It should also be noted that some lower abundance proteins may have been lost during albumin depletion by immunoaffinity, either through binding to albumin, which can act as a carrier protein, and/or through interactions with the chromatography column. 55, 56 However, albumin depletion, a widely practiced and generally accepted pre-fractionation method in proteomics, 23, 56 was performed to improve, overall, the detection of lower abundance proteins in the SF samples.
Although contamination of the SF with red blood cell proteins or blood plasma proteins could not be avoided completely (see Materials and Methods), the similar abundance in the two patient groups of hemoglobin (a protein present exclusively in red blood cells) and of the 9 most abundant proteins in blood plasma (excluding albumin) 16 (Supplementary Material, Table S1 ), indicates limited interference from contamination.
Finally, complementary techniques such as enzymelinked immunosorbant assays (ELISA) could be used in future studies to quantify selected proteins of interest identified by the proteomic analysis (particularly those highly specific and sensitive to one group). These proteins could then potentially be used as biomarkers.
CONCLUSION
The results of the present study are consistent with the presence of an adaptive immune response in the patients with a short-term MoM hip implant associated with a pseudotumor, and the predominance of an innate immune response in the patients with a longterm MoPE hip implant associated with periprosthetic osteolysis. More specifically, the differentially abundant proteins identified in the pseudotumor group suggest the presence of a type-IV hypersensitivity reaction, necrosis, and greater oxidative stress in this group. Differentially abundant proteins involved in oxidative stress, tissue remodeling, and apoptosis were also identified in both patient groups, although differences in the specific proteins identified suggest differences in the pathomechanisms.
Overall, the differentially abundant proteins identified provide insights into the pathomechanisms underlying metal-related pseudotumors and may ultimately help elucidate their etiology and assess the risk that asymptomatic pseudotumors will develop into aggressive lesions. In addition, a potential biomarker of metal-related pseudotumors (6-phosphogluconate dehydrogenase) and a potential biomarker of PE-related osteolysis (scavenger receptor cysteine-rich type 1 protein M130) were identified.
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